합성생물학 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Synthetic Biology Market Summary

The global synthetic biology market size was estimated at USD 18.94 billion in 2025 and is projected to reach USD 69.18 billion by 2033, growing at a CAGR of 17.7% from 2026 to 2033. Emerging applications of synthetic biology in areas such as multiplexed diagnostics, cellular recording, and therapeutic genome editing are projected to lead to a substantial rise in demand for synthetic products over the forecast period.

Furthermore, the integration of synthetic biology-based products and techniques into sectors such as energy and chemicals is likely to boost overall market growth. As these applications diversify further, the utility of synthetic biology is expected to increase, promoting further adoption and market growth.

Global Synthetic Biology Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the synthetic biology market on the basis of product, technology, application, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Oligonucleotide/Oligo Pools and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Xeno-Nucleic Acids
• Chassis Organism
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• NGS Technology
• PCR Technology
• Genome Editing Technology
• Bioprocessing Technology
• Other Technologies
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Healthcare
  • Clinical
  • Bio/Pharmaceuticals
  • Diagnostics
  • Non-Clinical
• Non-healthcare
  • Biotech Crops
  • Specialty Chemicals
  • Bio-fuels
  • Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Biotechnology and Pharmaceutical companies
• Academic and Research Institutes
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Technology Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use Segment
• 1.3. Information Analysis
  • 1.3.1. Market Formulation & Data Visualization
• 1.4. Data Validation & Publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Increasing Applications of Synthetic Biology
  • 3.3.2. Growing Funding and Assistance from Government and Private Organization
  • 3.3.3. Growing Research and Development Activities in Synthetic Biology
• 3.4. Market Restraint Analysis
  • 3.4.1. Biosafety and Biosecurity Issue
  • 3.4.2. Ethical Issues and Unintended Consequences
• 3.5. Industry Analysis Tools
  • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.5.2. Porter's Five Forces Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Synthetic Biology Market: Product Movement Analysis
• 4.3. Global Synthetic Biology Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Oligonucleotide/Oligo pools and Synthetic DNA
  • 4.4.1. Oligonucleotide/Oligo pools and Synthetic DNA Market, 2021 - 2033 (USD Million)
• 4.5. Enzymes
  • 4.5.1. Enzymes Market, 2021 - 2033 (USD Million)
• 4.6. Cloning Technologies Kits
  • 4.6.1. Cloning Technologies Kits Market, 2021 - 2033 (USD Million)
• 4.7. Xeno-nucleic Acids
  • 4.7.1. Xeno-nucleic Acids Market, 2021 - 2033 (USD Million)
• 4.8. Chassis Organism
  • 4.8.1. Chassis Organism Market, 2021 - 2033 (USD Million)

Chapter 5. Technology Business Analysis

• 5.1. Technology Segment Dashboard
• 5.2. Global Synthetic Biology Market: Technology Movement Analysis
• 5.3. Global Synthetic Biology Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 5.4. PCR
  • 5.4.1. PCR Market, 2021 - 2033 (USD Million)
• 5.5. Genome Editing
  • 5.5.1. Genome Editing Market, 2021 - 2033 (USD Million)
• 5.6. NGS
  • 5.6.1. NGS Market, 2021 - 2033 (USD Million)
• 5.7. Bioprocessing Technology
  • 5.7.1. Bioprocessing Technology Market, 2021 - 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Global Synthetic Biology Market: Application Movement Analysis
• 6.3. Global Synthetic Biology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Synthetic Biology Market: Technology Movement Analysis
• 6.5. Healthcare
  • 6.5.1. Healthcare Market, 2021 - 2033 (USD Million)
  • 6.5.2. Clinical
    • 6.5.2.1. Clinical Market, 2021 - 2033 (USD Million)
    • 6.5.2.2. Bio/Pharmaceuticals
      • 6.5.2.2.1. Bio/Pharmaceuticals Market, 2021 - 2033 (USD Million)
    • 6.5.2.3. Diagnostics
      • 6.5.2.3.1. Diagnostics Market, 2021 - 2033 (USD Million)
  • 6.5.3. Non-Clinical
    • 6.5.3.1. Non-Clinical Market, 2021 - 2033 (USD Million)
• 6.6. Non-Healthcare
  • 6.6.1. Non-Healthcare Market, 2021 - 2033 (USD Million)
  • 6.6.2. Biotech Crops
    • 6.6.2.1. Biotech Crops Market, 2021 - 2033 (USD Million)
  • 6.6.3. Specialty Chemicals
    • 6.6.3.1. Specialty Chemicals Market, 2021 - 2033 (USD Million)
  • 6.6.4. Bio-Fuels
    • 6.6.4.1. Bio-Fuels Market, 2021 - 2033 (USD Million)
  • 6.6.5. Others
    • 6.6.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global Synthetic Biology Market: End Use Movement Analysis
• 7.3. Global Synthetic Biology Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Biotechnology and Pharmaceutical Companies
  • 7.4.1. Biotechnology and Pharmaceutical Companies Market, 2021 - 2033 (USD Million)
• 7.5. Academic & Research Institutes
  • 7.5.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. North America Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Synthetic Biology Market, 2021 - 2033 (USD MILLION)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Synthetic Biology Market, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. Germany Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.4.3. UK
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. UK Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Synthetic Biology Market, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. South Korea Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Australia Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Thailand Synthetic Biology Market, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Synthetic Biology Market, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Synthetic Biology Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2025
• 9.4. Participant's Overview
  • 9.4.1. Bota Biosciences Inc.
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Codexis, Inc.
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Creative Biogene
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Creative Enzymes
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Enbiotix, Inc.
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Illumina, Inc.
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. Merck KGaA
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. New England Biolabs
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Eurofins Scientific
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Novozymes
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives
  • 9.4.11. Pareto Bio, Inc.
    • 9.4.11.1. Overview
    • 9.4.11.2. Financial Performance
    • 9.4.11.3. Product Benchmarking
    • 9.4.11.4. Strategic Initiatives
  • 9.4.12. Scarab Genomics, Inc.
    • 9.4.12.1. Overview
    • 9.4.12.2. Financial Performance
    • 9.4.12.3. Product Benchmarking
    • 9.4.12.4. Strategic Initiatives
  • 9.4.13. Synthego
    • 9.4.13.1. Overview
    • 9.4.13.2. Financial Performance
    • 9.4.13.3. Product Benchmarking
    • 9.4.13.4. Strategic Initiatives
  • 9.4.14. Synthetic Genomics Inc.
    • 9.4.14.1. Overview
    • 9.4.14.2. Financial Performance
    • 9.4.14.3. Product Benchmarking
    • 9.4.14.4. Strategic Initiatives
  • 9.4.15. Thermo Fisher Scientific, Inc.
    • 9.4.15.1. Overview
    • 9.4.15.2. Financial Performance
    • 9.4.15.3. Product Benchmarking
    • 9.4.15.4. Strategic Initiatives